See also this year's filing and all EDGAR filings for this company.
PDF Report 0001832511_2023_P3_Health_Partners_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Assets', 'missing_ratio': 0.4695325123301764, 'aggregate_val': 876571000, 'exp_sum': 1652450000, 'exp_to_value': {'IntangibleAssets': 751050000, 'AssetsNonCurrent': 775879000, 'AssetsCurrent': 100692000, 'PropertyPlantAndEquipment': 8839000, 'remainder_Assets': 15990000}} |
Graph
Absolute values for 0001832511, P3 Health Partners Inc
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 751,050,000 |
| 1 | AssetsNonCurrent | 775,879,000 |
| 2 | AssetsCurrent | 100,692,000 |
| 3 | PropertyPlantAndEquipment | 8,839,000 |
| 4 | remainder_Assets | -759,889,000 |
| 5 | LongTermLiabilities | 112,248,000 |
| 6 | LiabilitiesCurrent | 241,664,000 |
| 7 | remainder_Liabilities | 0 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 0 |
| 10 | GeneralAndAdministrativeExpense | 157,284,000 |
| 11 | GoodwillImpairmentLoss | 1,314,952,000 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 87,289,000 |
| 14 | SellingAndMarketingExpense | 5,096,000 |
| 15 | ResearchAndDevelopmentExpense | 0 |
| 16 | remainder_Expenses | 1,047,625,000 |
| 17 | remainder_Revenues | 1,049,471,000 |
| 18 | remainder_NetIncome | 1,218,000 |
| 19 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 876,571,000 |
| 1 | Liabilities | 353,912,000 |
| 2 | Expenses | 2,612,246,000 |
| 3 | Revenues | 1,049,471,000 |
| 4 | StockholdersEquity | 522,659,000 |
| 5 | NetIncome | -1,561,557,000 |
| 6 | ComprehensiveNetIncome | -1,561,557,000 |
| 7 | BaseVar | 2,446,709,000 |
| 8 | EconomicCapitalRatio | -0.176 |
Edgar->Model Mapping
Feature Distribution
